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Nowhere in the field of cancer treatment is there more controversy
and confusion than is the case with prostate cancer, according to
Professor Fred Stephens in his book with the grand title of ‘All
About Prostate Cancer’. 
The prostate is the site of two of the conditions that most
frequently afflict elderly men, benign prostatic hyperplasia and
prostate cancer. As men age, their prostates increase in size, even-
tually causing irritation and obstruction of the bladder. Benign
prostatic hyperplasia is not usually life-threatening, and can be
managed with drugs or surgery. The same symptoms can also be
caused by prostate cancer, now the most frequently diagnosed
cancer in men and one of the major killers due to cancer. 
Prostate cancer is lethal, and yet most men die with, rather than
of, the disease. If a man lives long enough, he will almost certainly
have microscopic evidence of prostate cancer at autopsy. Prostate
cancer tends to grow slowly and present late in life and it is these
two characteristics that lead to the controversy and confusion over
treatment. 
Fred Stephens took up his pen after retiring as Head of Surgery
at the University of Sydney Medical School in Australia. He
describes the choices given to men faced with a diagnosis of pros-
tate cancer. For early disease, still localized within the prostate,
difficult decisions must be made. For cancer that has spread
beyond the prostate, there is less debate and almost the only course
of action that will extend survival is castration, medical or
surgical. 
Almost everyone in the cancer business has stressed the need
for early diagnosis and treatment as the best, and almost the only,
opportunity for an individual to beat his or her cancer. Yet in pros-
tate cancer we are unsure about the value of screening and early
diagnosis. Perhaps this is less surprising when we accept that we
do not always know whether it is worth treating the disease, even
when it has been diagnosed. For many patients, and particularly
those over 70 with about 10 years or so left of their lives, a ‘watch
and wait’ policy is preferred. Fred Stephens gently rambles around
these issues, without being prescriptive or taking sides, and repeats
the more important points many times. 
So why would a man want to leave a cancer inside him, letting it
grow and perhaps metastasize, spurning the brief window of
opportunity of being cured. There is no short or easy answer to this
question – the issues are complex and debated with great intensity.
First of all, there is life expectancy. If you are a man over 70 years
old with perhaps another 10 years to live, do you want a therapy
with many unpleasant side-effects for a disease that is unlikely to
kill you before you die of something else? If you are less than 70
years old, you will probably opt for one of two treatments, radical
prostatectomy or radical radiotherapy, and accept the variable
degree of impotence and incontinence that will result. 
Radical therapy has the potential to cure prostate cancer. But
medical opinion can change rapidly. Only a decade ago it was said
that cure was not necessary in many of the men in whom it was
possible and cure was no longer possible in many of the men in
whom it was needed. Is this still true? It is a fact that staging proce-
dures are of limited accuracy. Consequently 30–40% of men given
radical treatment have disease that extends beyond the prostate.
The other side of the coin is that some of the men who are cured did
not need the treatment, at least to the extent that the disease would
not have caused them medical problems within their lifetime.
Prostate cancer has developed a high profile and this book adds
an Australian dimension to an avalanche of books, pamphlets and
information on the world wide web. Fred Stephens shares his
beliefs, his attitudes and what he considers to be the best treatment
with us. He does not tell us why he wrote the book or whom it is
for. There is an implication that the book is for a lay audience, but
he often seems to be addressing fellow professionals, and con-
sequently misses the target for both audiences. 
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